22 release. Specifically, patients who received a daily dose of 400 µg cebranopadol for two days saw a 1.34 mean hourly difference from placebo in their pain scale. The drug also demonstrated a ...

NRS also showed higher reproducibility when measuring pain exacerbations (Cohen's K of 0.86 for NRS vs. 0.53 for VRS) while the reproducibility of the two scales was similar in evaluating ...

"AI-Generated Enhanced Audio Descriptions help make video content more accessible and inclusive without hours of manual effort," said Nathan Arora, Chief Business Officer at YuJa, Inc. "Not only does ...